Log in
Mental and behavioural disorders

Derealization

Derealization is a dissociative symptom in which a person's surroundings feel unreal, dreamlike, foggy, or visually distorted, despite intact reality testing. It commonly occurs with depersonalization (feeling detached from one's own body or thoughts) and is seen across anxiety, panic, depression, PTSD, and substance use, as well as as a standalone disorder. The single most testable fact: reality testing remains intact — patients know the experience isn't real, which distinguishes it from psychosis.

ICD-10F48.1 (Depersonalization-derealization syndrome)
Typical patientYoung adult with anxiety or recent severe stress/trauma
Key findingPreserved reality testing despite feeling detached or unreal
First-line treatmentCBT; SSRIs if comorbid anxiety/depression present
6 min readFor medical studentsUpdated 2026-10-14

Definition and epidemiology

Derealization is a dissociative phenomenon characterized by a subjective sense that one's surroundings are unreal, distant, foggy, dreamlike, flat, or visually distorted. It is distinct from but frequently co-occurs with depersonalization, the sense of detachment from one's own body, thoughts, or self. When persistent or recurrent episodes of either or both cause significant distress or impairment, and are not better explained by another condition, the diagnosis is depersonalization-derealization disorder (DDD), coded F48.1 in ICD-10.

  • Transient derealization is extremely common — brief episodes occur in up to half of the general population at some point, often during stress, sleep deprivation, or substance use.
  • Depersonalization-derealization disorder as a chronic condition is less common, with lifetime prevalence estimates around 1-2%.
  • Onset is typically in adolescence or early adulthood; mean age of onset is often cited around 16 years, with onset after age 40 being unusual.
  • No strong sex predominance is established, unlike many other anxiety-spectrum conditions.
High-yield for exams
  • Reality testing is intact in derealization — this is the key feature separating it from psychosis.
  • F48.1 covers depersonalization-derealization syndrome in ICD-10.
  • Childhood emotional abuse/neglect is one of the strongest risk factors for chronic DDD.
  • Neuroimaging shows prefrontal hyperactivation with amygdala/insula hypoactivation (emotional blunting model).
  • Cannabis and hallucinogens are classic substance triggers of acute derealization.
  • CBT is first-line treatment; SSRIs mainly treat comorbid anxiety/depression, not derealization specifically.
  • Always rule out temporal lobe epilepsy and substance use before diagnosing DDD.
  • Course is typically chronic and fluctuating, often triggered or worsened by stress.

Etiology and risk factors

Derealization arises from a combination of psychological stress, trauma, and neurobiological dysregulation of circuits involved in emotional processing and interoception.

Risk factors

  • History of childhood emotional abuse or neglect (one of the strongest associated risk factors)
  • Severe or acute stress, trauma, or life-threatening events
  • Panic disorder and other anxiety disorders
  • Major depressive disorder
  • Post-traumatic stress disorder
  • Substance use, especially cannabis, hallucinogens (including ketamine, LSD), and sometimes alcohol withdrawal
  • Sleep deprivation and migraine
  • Certain personality traits (e.g., high harm avoidance, alexithymia)

Common triggers of acute episodes

  • Panic attacks
  • Marijuana or hallucinogen use
  • Severe emotional or physical stress
  • Sleep loss

Pathophysiology

The leading model views derealization-depersonalization as a protective dissociative response to overwhelming stress or threat, mediated by prefrontal cortical inhibition of limbic (emotion-generating) regions, particularly the amygdala.

  • Functional imaging studies show hyperactivation of prefrontal regions with corresponding hypoactivation of the amygdala and insula, suggesting a top-down suppression of emotional and interoceptive processing.
  • This blunting of emotional and bodily (interoceptive) signals is thought to produce the subjective sense of unreality and detachment — essentially an "anesthesia" of normal affective experience.
  • Disruption of sensory integration and altered activity in visual association areas may contribute to the perceptual distortions (flatness, altered depth or color perception) often described.
  • Autonomic findings sometimes include blunted skin conductance responses to emotional stimuli, consistent with dampened sympathetic reactivity.
  • The symptom is conceptualized as existing on a dissociative spectrum shared with acute stress disorder and PTSD, rather than being a fixed, isolated abnormality.

Clinical features

Patients describe the experience in strikingly consistent language, which is itself a diagnostic clue.

Derealization symptoms

  • World feels "foggy," "dreamlike," "like a movie or a video game," or "behind glass"
  • Objects may appear distorted in size, shape, color, or distance
  • Sounds may seem muffled or unnaturally loud
  • Time may feel distorted (too fast or too slow)

Associated depersonalization symptoms

  • Feeling like an outside observer of one's own thoughts, feelings, or body
  • Emotional numbing or feeling "robotic"
  • Body parts feeling disconnected or not belonging to oneself

Key clinical point

Patients remain acutely aware the experience is not real — insight and reality testing are preserved. This is what separates derealization from a psychotic process. Episodes can last minutes to years and often wax and wane with stress and anxiety levels.

Diagnosis

Diagnosis is clinical, based on history, after excluding other causes.

Diagnostic criteria (DSM-5/ICD-11 concept, mirrored in ICD-10 F48.1)

  • Persistent or recurrent episodes of depersonalization, derealization, or both
  • Reality testing remains intact during episodes
  • Symptoms cause clinically significant distress or functional impairment
  • Symptoms are not attributable to substance use or another medical condition
  • Symptoms are not better explained by another mental disorder (schizophrenia, panic disorder, major depressive disorder, PTSD, acute stress disorder, another dissociative disorder)

Work-up

  • Detailed psychiatric history, including trauma history, substance use, and screening for anxiety/depression/PTSD
  • Standardized scales can help quantify severity (e.g., Cambridge Depersonalization Scale, Dissociative Experiences Scale)
  • Basic medical screen to exclude organic mimics: neurologic exam, consideration of EEG (to exclude temporal lobe epilepsy or complex partial seizures), and toxicology screen if substance use suspected
  • Neuroimaging (MRI) is not routinely required unless focal neurologic signs or atypical features (e.g., abrupt onset in an older adult) are present

Differential diagnosis

ConditionDistinguishing feature
Psychotic disorders (schizophrenia)Impaired reality testing, delusions, hallucinations — insight is lost
Panic disorderDerealization occurs only during discrete panic attacks with autonomic surge
PTSD / acute stress disorderDissociation tied closely to trauma reminders; other PTSD criteria present
Temporal lobe epilepsyStereotyped, brief episodes, may have other ictal features, abnormal EEG
Substance intoxication/withdrawalTemporal relationship to use; resolves with abstinence
Migraine with auraAssociated headache and visual aura features
Major depressive disorder with dissociative featuresMood symptoms predominate; derealization secondary
Dissociative identity disorderDistinct identity states and amnesia present

Management

There is no single approved pharmacologic treatment specific to derealization-depersonalization disorder; management follows a stepwise, guideline-informed approach addressing underlying contributors and using psychotherapy as the mainstay.

Psychotherapy (first-line)

  • Cognitive behavioral therapy (CBT) is the best-supported approach: psychoeducation (symptom is not dangerous or indicative of "going crazy"), grounding techniques, and cognitive restructuring of catastrophic interpretations
  • Mindfulness-based and grounding techniques (five-senses grounding, physical sensation anchoring) help reduce symptom-related anxiety
  • Psychodynamic therapy may help address underlying trauma in select patients
  • Treating comorbid conditions (panic disorder, PTSD, depression) often substantially improves derealization

Pharmacotherapy (adjunctive, not disorder-specific)

  • SSRIs are the most commonly used agents, mainly to treat comorbid anxiety or depression; evidence for direct effect on derealization itself is limited
  • Lamotrigine has some supporting evidence as an add-on in treatment-resistant cases
  • Benzodiazepines may give short-term symptomatic relief during acute severe episodes but are not recommended for long-term use given dependence risk and limited disorder-specific efficacy
  • Avoid substances that commonly trigger episodes (cannabis, hallucinogens)

General measures

  • Address sleep hygiene and stress reduction
  • Lifestyle modification and reassurance reduce symptom-focused anxiety, which otherwise perpetuates a vicious cycle (anxiety about the symptom worsens the symptom)

Complications and prognosis

  • Course is often chronic and fluctuating, with symptoms waxing and waning in relation to stress; some patients have a single episode that resolves, while others have a persistent or episodic course over years.
  • Significant functional impairment can occur due to difficulty concentrating, impaired emotional engagement, and secondary anxiety about the symptom itself.
  • Comorbid anxiety and depressive disorders are common and often drive treatment-seeking.
  • Prognosis is generally favorable with treatment of underlying anxiety/mood conditions and CBT, though complete symptom resolution is not universal.
  • Suicidality is not a core feature but should be screened for given comorbid depression; the symptom itself does not indicate psychosis or impending loss of control, which is an important point for patient reassurance.
Mnemonic

DREAM: Detachment, Reality testing intact, Emotional numbing, Associated with anxiety/trauma, Movie-like/foggy perception

Practice questions

1. A 19-year-old college student presents after a panic attack during an exam. She reports that for the past month, during stressful moments, the classroom suddenly feels "foggy and unreal, like I'm watching myself from outside my body." She knows the feeling isn't real and finds it extremely distressing. Neurologic exam and toxicology screen are normal. Which of the following is the most likely diagnosis?

Answer: B. Preserved reality testing combined with recurrent episodes of feeling detached from the body (depersonalization) and the environment feeling unreal (derealization), causing distress, is classic for depersonalization-derealization disorder. Schizophrenia and delirium involve impaired reality testing or altered consciousness, which are absent here. Normal EEG workup and lack of stereotyped ictal features argue against seizure.

2. A 24-year-old man who smokes cannabis regularly reports recurrent episodes over the past 6 months where his surroundings feel "like a dream" and sounds seem muffled, lasting several hours after use and sometimes persisting into the next day. He has no history of psychotic symptoms, and the episodes resolve with abstinence periods. What is the best next step in confirming a diagnosis of primary depersonalization-derealization disorder rather than substance-induced symptoms?

Answer: B. Because the episodes are temporally linked to cannabis use, substance-induced derealization must be excluded before diagnosing a primary dissociative disorder; this requires confirming symptoms persist despite abstinence. MRI and EEG are reserved for atypical presentations or seizure concern, not routine confirmation. Antipsychotics are not indicated since reality testing is intact and there's no psychosis.

3. A 32-year-old woman with a history of childhood emotional neglect presents with a 3-year history of chronic derealization and depersonalization, significantly impairing her job performance. She has tried mindfulness apps without improvement. Which treatment has the strongest evidence base as first-line therapy for this condition?

Answer: C. CBT, incorporating psychoeducation, grounding techniques, and cognitive restructuring, has the strongest evidence base and is considered first-line for depersonalization-derealization disorder. Benzodiazepines may help acutely but carry dependence risk and aren't recommended long-term. Lamotrigine has some evidence only as an adjunct in treatment-resistant cases, not as first-line monotherapy, and ECT and antipsychotics are not indicated.

Frequently asked questions

What causes derealization?

Derealization is most often triggered by severe stress, trauma, panic attacks, or substance use (especially cannabis and hallucinogens), acting on a brain that responds to overwhelming emotion by dampening limbic activity through prefrontal inhibition. Childhood emotional abuse or neglect is a strong risk factor for the chronic form. It can also occur as part of panic disorder, PTSD, depression, sleep deprivation, or migraine, rather than as a standalone condition in many cases.

What are the first symptoms of derealization?

The earliest symptoms are usually a sense that surroundings feel foggy, dreamlike, flat, or like watching a movie, often accompanied by muffled sounds or distorted perception of distance and size. These episodes frequently appear suddenly during a panic attack or period of acute stress. Patients typically remain fully aware the experience isn't real, which is an important early clue distinguishing it from psychosis.

How is derealization diagnosed?

Derealization is diagnosed clinically through a detailed psychiatric history confirming persistent or recurrent episodes with preserved reality testing, significant distress or impairment, and exclusion of substances, seizures, and other psychiatric disorders. Standardized scales like the Cambridge Depersonalization Scale can help quantify severity. There is no blood test or imaging study that confirms the diagnosis; EEG and toxicology are used mainly to rule out mimics.

Is derealization curable?

Derealization is often manageable rather than definitively "cured," with many patients achieving significant symptom reduction through cognitive behavioral therapy and treatment of underlying anxiety, depression, or trauma. Some people have a single self-limited episode, while others experience a chronic, fluctuating course. Early treatment and avoiding triggers like cannabis generally improve long-term outcomes.

Derealization vs depersonalization — what is the difference?

Derealization refers to the external world feeling unreal, foggy, or dreamlike, while depersonalization refers to feeling detached from one's own body, thoughts, or sense of self. The two frequently occur together and are grouped under the same ICD-10 code (F48.1) and DSM-5 diagnosis, but a person can experience one without the other. Both share the hallmark of preserved reality testing.

Key drugs

FluoxetineSertralineEscitalopramLamotrigineClonazepamLorazepam
Panic disorderPost-traumatic stress disorderAcute stress disorderDissociative identity disorderGeneralized anxiety disorderMajor depressive disorderTemporal lobe epilepsyMigraine with aura

Sources and further reading

StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F48.1

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.